Leadiant's antitrust fine welcomed by Pharmaceutical Accountability Foundation
MLex Summary: The Pharmaceutical Accountability Foundation has observed how its enforcement request on Leadiant led the Dutch competition authority to impose a 19.5 million-euro fine. The PAF said that it welcomes the ACM's decision,...To view the full article, register now.
Already a subscriber? Click here to view full article